NCT02350205

SASS 2 : Self Assembled Skin Substitute for the Autologous Treatment of Severe Burn Wounds in Acute Stage of Burn Trauma

SASS 2 : Self Assembled Skin Substitute for the Autologous Treatment of Severe Burn Wounds in Acute Stage of Burn Trauma.

• Status: Recruiting
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 52 (estimated)
• Sponsor: CHU de Quebec-Universite Laval · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

This clinical trial is designed to assess the safety, effectiveness and benefits of Self Assembled Skin Substitute SASS grafts as a permanent skin replacement for the treatment of full-thickness burn wounds that require permanent coverage where the availability of donor sites is limited.

Conditions

• Burns

Interventions

Type	Name	Description
BIOLOGICAL	Self assembled skin substitute (SASS)	All patients in Phase B will receive Self assembled skin substitute (SASS)

Timeline

• Start date: 2015-12-01
• Primary completion: 2028-01-01
• Completion: 2029-01-01
• First posted: 2015-01-29
• Last updated: 2025-07-25

Locations

7 sites across 1 country: Canada